268 filings
Page 5 of 14
8-K
vmos21rbu
4 Mar 21
Larimar Therapeutics Reports Fourth Quarter and Full Year 2020 Operating and Financial Results
7:30am
8-K
k6yc7ves06rgnhf
8 Dec 20
Regulation FD Disclosure
7:40am
8-K/A
yrd347
12 Nov 20
Unaudited Pro Forma Combined Financial Statements
4:51pm
8-K
xh52gn3j
10 Nov 20
Larimar Therapeutics Reports Third Quarter 2020 Operating and Financial Results
4:23pm
8-K
2fqie13g89xdezrmmg
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
S-8
ei67fkjkotmh zy8
2 Oct 20
Registration of securities for employees
5:19pm
8-K/A
5x867z4g90fviuzj
29 Sep 20
Departure of Directors or Certain Officers
4:39pm
8-K
kxdcs
29 Sep 20
Departure of Directors or Certain Officers
7:06am
EFFECT
8tcqc2n4 ifnt7q8a
2 Sep 20
Notice of effectiveness
12:15am
CORRESP
6usfa0x6tc kv
31 Aug 20
Correspondence with SEC
12:00am
UPLOAD
50sf8r0nasr r9q89tx
24 Aug 20
Letter from SEC
12:00am
DEFA14A
d0i9if4 q2aa0
19 Aug 20
Additional proxy soliciting materials
6:13am
8-K/A
bke497aslr1okefa243r
14 Aug 20
Unaudited Pro Forma Combined Financial Statements
4:56pm
8-K
ntirralauw360
11 Aug 20
Larimar Therapeutics Reports Second Quarter 2020 Operating and Financial Results
7:38am
8-K
mkfyr9mwvd yp7fa
6 Aug 20
Departure of Directors or Certain Officers
9:00am
EFFECT
q1q035
15 Jul 20
Notice of effectiveness
12:15am